M&A Deal Summary

Pharmascience Acquires Aegera Therapeutics

On May 27, 2011, Pharmascience acquired life science company Aegera Therapeutics

Acquisition Highlights
  • This is Pharmascience’s 1st transaction in the Life Science sector.
  • This is Pharmascience’s 1st transaction in Canada.
  • This is Pharmascience’s 1st transaction in Quebec.

M&A Deal Summary
Date 2011-05-27
Target Aegera Therapeutics
Sector Life Science
Buyer(s) Pharmascience
Deal Type Add-on Acquisition
Advisor(s) Torreya Partners LLC (Financial)

Target

Aegera Therapeutics

Montreal, Quebec, Canada
Aegera Therapeutics Inc., a Montreal-based clinical-stage biotechnology company focused on developing targeted therapeutics to address thus far unmet major medical needs, primarily in oncology.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Pharmascience

Montreal, Quebec, Canada
Category Company
Founded 1983
Sector Healthcare Services
DESCRIPTION

Pharmascience, the largest generic pharmaceutical company.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Quebec) 1 of 1
Country (Canada) 1 of 1
Year (2011) 1 of 1
Mergr

Product

Company

Legal